Quick Answer Psilocybin and other psychedelics show real, measurable promise for depression, particularly treatment-resistant cases. But the evidence in 2026 is more complicated, more honest, and more nuanced than headlines suggest. Whether this path is right for you...
Quick answer: Microdosing psychedelics means taking very small, sub-perceptual doses of substances such as psilocybin or LSD, usually on a repeated schedule rather than in a single full journey. While many people report benefits like improved mood and focus,...
Quick answer: A LSD For Anxiety randomized, placebo-controlled Phase 2b trial published in JAMA found that a single oral dose of MM120, an investigational LSD formulation developed by MindMed, produced significant reductions in generalized anxiety disorder symptoms...
The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time, and questions about who was enrolled in the trials. The MDMA...
A peer-reviewed study in npj Aging found that psilocybin and aging may be more connected than previously assumed, after treated female mice showed reduced oxidative stress, better-preserved telomeres, and longer lifespans than untreated controls. These are genuine...
RFK Jr. psychedelic therapy support has brought real political attention to substances like psilocybin, MDMA, and ibogaine. For seekers already exploring this space, the shift matters. It does not, however, change what responsible engagement looks like at the...
